Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-21-052285

Director sold 6,000 shares at an average $95.44 ($572,644)

  • Director acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McLoughlin Margaret · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-16 Exercise or conversion : show line 1 in the form +6,000 $17.00 $102,000 6,000 D
2021-08-16 Sale : show line 2 in the form −3,056 $94.55 $288,945 2,944 D
2021-08-16 Sale : show line 3 in the form −1,044 $95.57 $99,775 1,900 D
2021-08-16 Sale : show line 4 in the form −1,429 $96.51 $137,913 471 D
2021-08-16 Sale : show line 5 in the form −423 $97.55 $41,264 48 D
2021-08-16 Sale : show line 6 in the form −48 $98.90 $4,747 0 D
Open-market sales · 6,000 sh · avg $95.44 · $572,644

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-16 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −6,000 85,911 D
Loading xslF345X03/doc4.xml…